Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of UTHR will rise by +8.67% over the next 2 Weeks and hit $476.18 by Wednesday, October 15, 2025. In that time frame, UTHR's share price is expected to range between $449.46 and $499.70.
BearishAverageBullishUTHR shares rose +1.20% in Thursday, October 2, 2025's trading session, rising from a previous close of $438.18 to move at $443.44. The stock demonstrated notable intraday movement (see UTHR's key stats for a full breakdown), fluctuating between $432.56 and $444.57, a +2.78% trading range. While recent weeks have seen some volatility, UTHR has managed to secure a +6.20% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 948.5K shares changing hands, 162.9K more than the previous session. This amounted to $420.60M in total market activity.
Will UTHR Continue Its Upward Trend?
According to analyst ratings and projections for UTHR, United Therapeutics Corporation shares are anticipated to increase by +11.26%, potentially reaching $499.70 per share by October 15, 2025. Short-term technical indicators currently suggest a neutral sentiment for UTHR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the UTHR stock forecast, now is a good time to buy UTHR stock because its current trading price is -6.88% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on UTHR covering social and institutional perspectives.
UTHR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into UTHR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 68.68% to 69.33%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 63.96%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 59.22%, maintains a neutral outlook for the long term. Insights into UTHR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
United Therapeutics Short-Term Forecasts
UTHR Forecast For Next 5 Days
Our algorithm anticipates United Therapeutics (UTHR) stock could hit $437.61 by Oct 09, 2025. This represents a -1.32% fall from today's price, following a -0.13% change over the past five days.
UTHR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for United Therapeutics Corporation (UTHR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $430.85, which would mean a -2.84% decrease from the current price of $443.44. Projections for this period range from a high of $462.61 to a low of $386.70.
UTHR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for United Therapeutics's price over the next three months point to a drop. UTHR stock is expected to peak at $505.30 on Nov 11, 2025 after potentially dipping to $412.97 on Oct 03, 2025. On average, UTHR is likely to trade around $434.82 in the coming 90 days.
United Therapeutics Stock Forecast 2025
Based on our predictive models, United Therapeutics (UTHR) is expected to trade between $412.97 and $505.30 throughout 2025. This would result in an average price of $434.82, potentially offering investors a -1.94% return from current levels.
United Therapeutics Corporation Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, United Therapeutics Corporation (UTHR) is positioned to show a strong performance in October 2025. The price is predicted to move between $412.97 and $454.64, settling at an average of $432.11. This could translate to a -2.56% loss.
November 2025
Based on current market signals, United Therapeutics Corporation is projected to trend november 2025. We forecast a trading range from $415.52 to $505.30, with a likely average price of $437.39. Investors could expect a potential return of -1.36%.
December 2025
Our predictive algorithms indicate United Therapeutics Corporation stock may see a shift in December 2025. The expected range spans $416.72–$454.15, with an average target of $435.17. This represents a cautious outlook and a possible loss of -1.86%.
January 2026
Analyzing established trends, United Therapeutics Corporation looks set to move in January 2026. Projections place the stock between $416.07 and $457.66, averaging around $435.86. This suggests a -1.71% loss from current levels.
February 2026
Market indicators suggest United Therapeutics Corporation could experience notable changes during February 2026. Prices could fluctuate within $428.17 to $473.59, with a midpoint forecast of $449.49. The stock might deliver a +1.36% gain.
March 2026
Forecasting for March 2026, models estimate that United Therapeutics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $429.46 and $471.89, averaging $449.93. This signals a positive trajectory with potential returns around +1.46%.
April 2026
According to our latest forecast models, United Therapeutics Corporation (UTHR) is positioned to show a strong performance in April 2026. The price is predicted to move between $434.10 and $471.65, settling at an average of $452.84. This could translate to a +2.12% gain.
May 2026
Based on current market signals, United Therapeutics Corporation is projected to trend may 2026. We forecast a trading range from $435.47 to $471.59, with a likely average price of $453.52. Investors could expect a potential return of +2.27%.
June 2026
Our predictive algorithms indicate United Therapeutics Corporation stock may see a shift in June 2026. The expected range spans $435.08–$476.82, with an average target of $454.21. This represents a positive outlook and a possible gain of +2.43%.
July 2026
Analyzing established trends, United Therapeutics Corporation looks set to move in July 2026. Projections place the stock between $446.77 and $489.49, averaging around $467.29. This suggests a +5.38% gain from current levels.
August 2026
Market indicators suggest United Therapeutics Corporation could experience notable changes during August 2026. Prices could fluctuate within $450.94 to $489.06, with a midpoint forecast of $469.27. The stock might deliver a +5.82% gain.
September 2026
Forecasting for September 2026, models estimate that United Therapeutics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $453.04 and $489.60, averaging $471.11. This signals a positive trajectory with potential returns around +6.24%.
October 2026
According to our latest forecast models, United Therapeutics Corporation (UTHR) is positioned to show a strong performance in October 2026. The price is predicted to move between $457.59 and $485.18, settling at an average of $471.61. This could translate to a +6.35% gain.
UTHR's history of dividends and stock splits also plays a role in long-term investor confidence.